Notification of Stolen Eli Lilly and Company Products

FDA posts press releases and other notices from firms as a service to consumers, the media, and other interested parties.

Eli Lilly and Company is working with the U.S. Food and Drug Administration’s Office of Criminal Investigations (FDA), and other law enforcement officials, to recover cases of select lots of pharmaceutical products that were stolen from one of Lilly’s United States distribution centers located in Enfield, Connecticut, on Sunday, March 14, 2010.  A list of products stolen from the facility can be found at the bottom of this notice.

Product from the affected lots which had been delivered from Lilly to retailers, wholesalers or institutions prior to March 14 is not affected by this event.  Product containing these lot numbers was previously distributed by Lilly within the United States, Puerto Rico and its territories. To assist the FDA and the law enforcement agencies in their investigation, Lilly stopped distributing product with the affected lot numbers on Monday, March 15, 2010.

These medicines require a prescription for purchase.  Practitioners, pharmacies, and consumers are advised to purchase Lilly products only from well-established, trusted, and reputable sources and to be aware that an unusually low price is often an indication that a product has been stolen.  Additionally, all pharmaceutical products should always be checked for signs of tampering or damage prior to purchase and/or use.  Pharmacists and other health care professionals should not use the product if it has been removed from the sealed bottle or container, if the induction seal has been compromised, or in the case of glass vials, if the flip cap appears to have been disturbed in any way. 

Anyone who has information regarding this incident or has received suspicious or unsolicited offers for the affected Eli Lilly products after the date of the theft is encouraged to contact the U.S. Food and Drug Administration (FDA) Office of Criminal Investigations at 1-800-551-3989 or by visiting the OCI Web Site (http://www.fda.gov/OCI).

For medical or other related inquiries about this matter, contact Lilly at 1-800-LILLYRX (1-800-545-5979).

Impacted Products